CALYPTE BIOMEDICAL CORP Financing Cash Flow
CALYPTE BIOMEDICAL CORP reported Financing Cash Flow of $687.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was $148.00K, a 4.23% increase year-over-year.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was $133.00K, a 121.67% increase year-over-year.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $86.00K, a 1.18% increase year-over-year.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $320.00K, a 247.83% increase year-over-year.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for fiscal 2012 was $687.00K, a 81.27% increase from fiscal 2011.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for fiscal 2011 was $379.00K, a 40.50% decline from fiscal 2010.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) financing activities for fiscal 2010 was $637.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2012-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $281.00K derived: sum of 2 quarters · filed 2014-06-24 | $367.00K derived: sum of 3 quarters · filed 2014-06-24 | $687.00K 10-K · filed 2014-06-24 |
| 2012-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | $219.00K derived: sum of 2 quarters · filed 2012-12-31 | $539.00K 10-Q · filed 2012-12-31 | $681.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $406.00K 10-Q · filed 2012-08-14 | $548.00K derived: sum of 3 quarters · filed 2014-06-24 | $608.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | $320.00K 10-Q · filed 2012-05-15 | $462.00K derived: sum of 2 quarters · filed 2014-06-24 | $522.00K derived: sum of 3 quarters · filed 2014-06-24 | $607.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $202.00K derived: sum of 2 quarters · filed 2014-06-24 | $287.00K derived: sum of 3 quarters · filed 2014-06-24 | $379.00K 10-K · filed 2014-06-24 |
| 2011-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | $145.00K derived: sum of 2 quarters · filed 2012-12-31 | $237.00K 10-Q · filed 2012-12-31 | $340.00K derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $177.00K 10-Q · filed 2012-08-14 | $280.00K derived: sum of 3 quarters · filed 2012-08-14 | $480.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $92.00K 10-Q · filed 2012-05-15 | $195.00K derived: sum of 2 quarters · filed 2012-05-15 | $395.00K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $303.00K derived: sum of 2 quarters · filed 2012-03-22 | $637.00K 10-K · filed 2012-03-22 | |
| 2010-09-30 | $200.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-27 | $534.00K 10-Q · filed 2012-01-27 | ||
| 2010-06-30 | $334.00K 10-Q/A · filed 2011-11-30 |